90 related articles for article (PubMed ID: 12527996)
21. Passive transfer of human myasthenia gravis to rats: 1. Electrophysiology of the developing neuromuscular block.
Howard JF; Sanders DB
Neurology; 1980 Jul; 30(7 Pt 1):760-4. PubMed ID: 7190241
[TBL] [Abstract][Full Text] [Related]
22. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.
Toyka KV; Drachman DB; Griffin DE; Pestronk A; Winkelstein JA; Fishbeck KH; Kao I
N Engl J Med; 1977 Jan; 296(3):125-31. PubMed ID: 831074
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis.
Tsujihata M; Yoshimura T; Satoh A; Kinoshita I; Matsuo H; Mori M; Nagataki S
Neurology; 1989 Oct; 39(10):1359-63. PubMed ID: 2797459
[TBL] [Abstract][Full Text] [Related]
24. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.
Engel AG; Lindstrom JM; Lambert EH; Lennon VA
Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772
[TBL] [Abstract][Full Text] [Related]
25. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.
Vincent A; Cull-Candy SG; Newsom-Davis J; Trautmann A; Molenaar PC; Polak RL
Muscle Nerve; 1981; 4(4):306-18. PubMed ID: 7254233
[TBL] [Abstract][Full Text] [Related]
26. Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. II. Receptor synthesis.
Wilson S; Vincent A; Newsom-Davis J
J Neurol Neurosurg Psychiatry; 1983 May; 46(5):383-7. PubMed ID: 6101172
[TBL] [Abstract][Full Text] [Related]
27. The immunopathology of myasthenia gravis.
Engel AG
Int J Neurol; 1980; 14(1):35-46. PubMed ID: 6293990
[No Abstract] [Full Text] [Related]
28. Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. I. Receptor degradation.
Wilson S; Vincent A; Newsom-Davis J
J Neurol Neurosurg Psychiatry; 1983 May; 46(5):377-82. PubMed ID: 6101171
[TBL] [Abstract][Full Text] [Related]
29. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.
Martínez-Martínez P; Losen M; Duimel H; Frederik P; Spaans F; Molenaar P; Vincent A; De Baets MH
Am J Pathol; 2007 Feb; 170(2):644-57. PubMed ID: 17255332
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6.
Biesecker G; Gomez CM
J Immunol; 1989 Apr; 142(8):2654-9. PubMed ID: 2703710
[TBL] [Abstract][Full Text] [Related]
32. Effects of long-term administration of ambenonium chloride on motor end-plate fine structure and acetylcholine receptor in rat.
Hazama R; Tsujihata M; Mori M; Takamori M; Mori K; Shibuya N
J Neurol Sci; 1981 Jul; 51(1):69-79. PubMed ID: 7252521
[TBL] [Abstract][Full Text] [Related]
33. Electrophysiological effects of myasthenic serum factors studied in mouse muscle.
Lerrick AJ; Wray D; Vincent A; Newsom-Davis J
Ann Neurol; 1983 Feb; 13(2):186-91. PubMed ID: 6830177
[TBL] [Abstract][Full Text] [Related]
34. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis.
Ruff RL; Lennon VA
Ann Neurol; 1998 Mar; 43(3):370-9. PubMed ID: 9506554
[TBL] [Abstract][Full Text] [Related]
35. The effects of myasthenic immunoglobulin G on the ultrastructure of mouse motor endplate.
Chen ML; Chiu HC; Tsai MC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 May; 23(2):120-5. PubMed ID: 2394186
[TBL] [Abstract][Full Text] [Related]
36. The motor end-plate fine structure and ultrastructural localization of acetylcholine receptors in amyotrophic lateral sclerosis.
Tsujihata M; Hazama R; Yoshimura T; Satoh A; Mori M; Nagataki S
Muscle Nerve; 1984; 7(3):243-9. PubMed ID: 6708970
[TBL] [Abstract][Full Text] [Related]
37. Acetylcholinesterase activity of skeletal muscle in a non-immunogenic model for myasthenia gravis in rats.
Van Kempen GT; Trip SA; Molenaar PC
J Neural Transm (Vienna); 1999; 106(5-6):423-31. PubMed ID: 10443548
[TBL] [Abstract][Full Text] [Related]
38. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
39. Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model.
Toyka KV; Birnberger KL; Anzil AP; Schlegel C; Besinger U; Struppler A
J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):746-53. PubMed ID: 210263
[TBL] [Abstract][Full Text] [Related]
40. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
Elias SB; Appel SH
Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
